Folic acid antagonists during pregnancy and the risk of birth defects

New England Journal of Medicine

Volumn 343, Issue 22, 2000, Pages 1608-1614

  Hernández Díaz, Sonia ^a,b   Werler, Martha M ^a   Walker, Alexander M ^b   Mitchell, Allen A ^a  

^a BOSTON UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIHYDROFOLATE REDUCTASE INHIBITOR; FOLIC ACID; FOLIC ACID ANTAGONIST;

ARTICLE; BIRTH DEFECT; CARDIOVASCULAR DISEASE; CLEFT PALATE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; URINARY TRACT DISEASE; VITAMIN SUPPLEMENTATION;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; CASE-CONTROL STUDIES; CLEFT LIP; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOLIC ACID ANTAGONISTS; HEART DEFECTS, CONGENITAL; HUMANS; LOGISTIC MODELS; PREGNANCY; URINARY TRACT; VITAMINS;

EID: 0034735832     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200011303432204     Document Type: Article

References (24)

1. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
2. Prevention of neural-robe defects with folic acid in China
3. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring
4. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation
5. Periconceptional multivitamin use and occurrence of conotruncal heart defects: Results from a population-based, case-control study
6. Population-based case control study of folic acid supplementation during pregnancy
7. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins
8. Risk of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally
9. Multivitamin supplementation and risk of birth defects
10. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies
11. Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring?
12. Drugs and folate metabolism
13. Birth defects related to Bendectin use in pregnancy. I. Oral clefts and cardiac defects
14. Special considerations in studies of drug-induced birth defects
15. Drugs in pregnancy and lactation
16. Neural tube defects in relation to use of folic acid antagonists during pregnancy
17. A case-control analysis of the teratogenic effects of co-trimoxazole
18. Trimethoprim and fasting plasma homocysteine
19. Drug-induced megaloblastic anemias
20. Anticonvulsant drugs: Mechanisms and pathogenesis of teratogenicity
21. Spina bifida in infants of women treated with carbamazepine during pregnancy
22. Anticonvulsant drugs and malformations: Is there a drug specificity?
23. Effect of questionnaire design on recall of drug exposure in pregnancy